Stereotactic Radiotherapy for Unilateral Orbital Lymphoma and Orbital Pseudo-Tumors: A Planning Study

Kazumi Chino, James Tanyi, Baldassarre Stea

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Orbital lymphoma and Grave's ophthalmopathy (GO) are successfully treated with radiation therapy. The lenses are blocked to prevent cataract formation. However, blocking of the lens by traditional methods can be difficult for tumors located anteriorly and extending into the retrobulbar space. We present a series of 3 patients with orbital lymphoma and 1 with GO treated with stereotactic intensity modulated radiation therapy (IMRT) to spare normal structures, including the lens. Three patients with orbital lymphomas and 1 with unilateral GO were treated with IMRT using a linac with stereotactic capabilities. Avoidance structures included the ipsilateral lens and globe, the contralateral lens and globe, the chiasm, and the brainstem. Two patients with orbital lymphoma were treated with 24 Gy in 12 fractions, and 1 patient was treated with 30.6 Gy in 17 fractions. The patient with GO was treated with 20 Gy in 10 fractions. The dosimetry was analyzed to determine the dose to normal tissues. Patient follow-up varies between 8 and 24 months. The mean minimal dose to the ipsilateral lens was 13.6% of the total dose, the mean maximal dose was 33.5%, and the mean median dose was 19.3%. The mean median dose to the contralateral eye was 1.1% of the total dose. The mean median dose to the chiasm was 14.9% of the total dose. The mean median dose to the brainstem was 1.9% of the total dose. No cataracts or other complications were noted in the 4 patients treated with this technique so far. IMRT gives a more conformal treatment to the orbital contents while sparing normal tissues such as the ipsilateral lens and adjacent critical structures. This should result in fewer complications such as cataracts.

Original languageEnglish (US)
Pages (from-to)57-62
Number of pages6
JournalMedical Dosimetry
Volume34
Issue number1
DOIs
StatePublished - Mar 2009

Fingerprint

Lenses
Radiotherapy
Graves Ophthalmopathy
Neoplasms
Cataract
Brain Stem
Orbital lymphoma

Keywords

  • Cataracts
  • Grave's ophthalmopathy
  • Orbital lymphoma
  • Stereotactic IMRT

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology

Cite this

Stereotactic Radiotherapy for Unilateral Orbital Lymphoma and Orbital Pseudo-Tumors : A Planning Study. / Chino, Kazumi; Tanyi, James; Stea, Baldassarre.

In: Medical Dosimetry, Vol. 34, No. 1, 03.2009, p. 57-62.

Research output: Contribution to journalArticle

@article{b7771d5432584cffb063ab8faf00f20c,
title = "Stereotactic Radiotherapy for Unilateral Orbital Lymphoma and Orbital Pseudo-Tumors: A Planning Study",
abstract = "Orbital lymphoma and Grave's ophthalmopathy (GO) are successfully treated with radiation therapy. The lenses are blocked to prevent cataract formation. However, blocking of the lens by traditional methods can be difficult for tumors located anteriorly and extending into the retrobulbar space. We present a series of 3 patients with orbital lymphoma and 1 with GO treated with stereotactic intensity modulated radiation therapy (IMRT) to spare normal structures, including the lens. Three patients with orbital lymphomas and 1 with unilateral GO were treated with IMRT using a linac with stereotactic capabilities. Avoidance structures included the ipsilateral lens and globe, the contralateral lens and globe, the chiasm, and the brainstem. Two patients with orbital lymphoma were treated with 24 Gy in 12 fractions, and 1 patient was treated with 30.6 Gy in 17 fractions. The patient with GO was treated with 20 Gy in 10 fractions. The dosimetry was analyzed to determine the dose to normal tissues. Patient follow-up varies between 8 and 24 months. The mean minimal dose to the ipsilateral lens was 13.6{\%} of the total dose, the mean maximal dose was 33.5{\%}, and the mean median dose was 19.3{\%}. The mean median dose to the contralateral eye was 1.1{\%} of the total dose. The mean median dose to the chiasm was 14.9{\%} of the total dose. The mean median dose to the brainstem was 1.9{\%} of the total dose. No cataracts or other complications were noted in the 4 patients treated with this technique so far. IMRT gives a more conformal treatment to the orbital contents while sparing normal tissues such as the ipsilateral lens and adjacent critical structures. This should result in fewer complications such as cataracts.",
keywords = "Cataracts, Grave's ophthalmopathy, Orbital lymphoma, Stereotactic IMRT",
author = "Kazumi Chino and James Tanyi and Baldassarre Stea",
year = "2009",
month = "3",
doi = "10.1016/j.meddos.2007.12.004",
language = "English (US)",
volume = "34",
pages = "57--62",
journal = "Medical Dosimetry",
issn = "0958-3947",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Stereotactic Radiotherapy for Unilateral Orbital Lymphoma and Orbital Pseudo-Tumors

T2 - A Planning Study

AU - Chino, Kazumi

AU - Tanyi, James

AU - Stea, Baldassarre

PY - 2009/3

Y1 - 2009/3

N2 - Orbital lymphoma and Grave's ophthalmopathy (GO) are successfully treated with radiation therapy. The lenses are blocked to prevent cataract formation. However, blocking of the lens by traditional methods can be difficult for tumors located anteriorly and extending into the retrobulbar space. We present a series of 3 patients with orbital lymphoma and 1 with GO treated with stereotactic intensity modulated radiation therapy (IMRT) to spare normal structures, including the lens. Three patients with orbital lymphomas and 1 with unilateral GO were treated with IMRT using a linac with stereotactic capabilities. Avoidance structures included the ipsilateral lens and globe, the contralateral lens and globe, the chiasm, and the brainstem. Two patients with orbital lymphoma were treated with 24 Gy in 12 fractions, and 1 patient was treated with 30.6 Gy in 17 fractions. The patient with GO was treated with 20 Gy in 10 fractions. The dosimetry was analyzed to determine the dose to normal tissues. Patient follow-up varies between 8 and 24 months. The mean minimal dose to the ipsilateral lens was 13.6% of the total dose, the mean maximal dose was 33.5%, and the mean median dose was 19.3%. The mean median dose to the contralateral eye was 1.1% of the total dose. The mean median dose to the chiasm was 14.9% of the total dose. The mean median dose to the brainstem was 1.9% of the total dose. No cataracts or other complications were noted in the 4 patients treated with this technique so far. IMRT gives a more conformal treatment to the orbital contents while sparing normal tissues such as the ipsilateral lens and adjacent critical structures. This should result in fewer complications such as cataracts.

AB - Orbital lymphoma and Grave's ophthalmopathy (GO) are successfully treated with radiation therapy. The lenses are blocked to prevent cataract formation. However, blocking of the lens by traditional methods can be difficult for tumors located anteriorly and extending into the retrobulbar space. We present a series of 3 patients with orbital lymphoma and 1 with GO treated with stereotactic intensity modulated radiation therapy (IMRT) to spare normal structures, including the lens. Three patients with orbital lymphomas and 1 with unilateral GO were treated with IMRT using a linac with stereotactic capabilities. Avoidance structures included the ipsilateral lens and globe, the contralateral lens and globe, the chiasm, and the brainstem. Two patients with orbital lymphoma were treated with 24 Gy in 12 fractions, and 1 patient was treated with 30.6 Gy in 17 fractions. The patient with GO was treated with 20 Gy in 10 fractions. The dosimetry was analyzed to determine the dose to normal tissues. Patient follow-up varies between 8 and 24 months. The mean minimal dose to the ipsilateral lens was 13.6% of the total dose, the mean maximal dose was 33.5%, and the mean median dose was 19.3%. The mean median dose to the contralateral eye was 1.1% of the total dose. The mean median dose to the chiasm was 14.9% of the total dose. The mean median dose to the brainstem was 1.9% of the total dose. No cataracts or other complications were noted in the 4 patients treated with this technique so far. IMRT gives a more conformal treatment to the orbital contents while sparing normal tissues such as the ipsilateral lens and adjacent critical structures. This should result in fewer complications such as cataracts.

KW - Cataracts

KW - Grave's ophthalmopathy

KW - Orbital lymphoma

KW - Stereotactic IMRT

UR - http://www.scopus.com/inward/record.url?scp=58749086934&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58749086934&partnerID=8YFLogxK

U2 - 10.1016/j.meddos.2007.12.004

DO - 10.1016/j.meddos.2007.12.004

M3 - Article

C2 - 19181257

AN - SCOPUS:58749086934

VL - 34

SP - 57

EP - 62

JO - Medical Dosimetry

JF - Medical Dosimetry

SN - 0958-3947

IS - 1

ER -